{
  "ptid_time": "057_S_4909_2012-08-23",
  "img_path": "/data/qiuhui/data/adni/images/057_S_4909/2012-08-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,496 mm³, 76.3% above the reference mean. With a Z-score of 1.75 (96.0th percentile), this represents moderate enlargement; hippocampal volume measures 5,921 mm³, 16.8% below the reference mean. With a Z-score of -1.54 (6.2th percentile), this represents moderate atrophy; whole brain volume measures 906,500 mm³, 7.0% below the reference mean. With a Z-score of -0.88 (18.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,465 mm³, 32.9% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,663 mm³, 7.9% below the reference mean. With a Z-score of -0.72 (23.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,594 mm³, 13.4% below the reference mean. With a Z-score of -1.17 (12.2th percentile), this represents mild atrophy. ",
  "text_data": "Age is 78.2 years. Gender is Female. Education: 11 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Hepatic; Musculoskeletal; Gastrointestinal; Major Surgical Procedures. MMSE: 25.0. MoCA: 22.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.65 SUVR (profound elevated); Amyloid beta: 781.00 pg/mL (normal ); Total tau: 355.80 pg/mL (mild elevated); Phosphorylated tau: 34.88 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). The moderate ventricular enlargement and mild atrophy in the middle temporal gyrus further support neurodegeneration. Clinically, the patient has mild cognitive impairment (MCI) based on MMSE (25) and MoCA (22), with biomarker evidence (elevated tau and AV45) suggesting amyloid pathology despite normal Aβ.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **High**  \n\n*(Note: The normal Aβ is atypical for AD, but elevated AV45 (amyloid PET) suggests amyloid deposition, possibly due to a discrepancy between CSF and PET measures. The tau elevation and imaging findings strongly point toward AD progression.)*",
  "timestamp": "2025-07-26T08:14:24.817074"
}